Atlas Trials

Extension Study of MT-1303

Clinical trial NCT01890655 · COMPLETED

Trial details

NCT number
NCT01890655
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsing-remitting Multiple Sclerosis
Start date
2013-08-01
Primary completion
2016-03-01
Enrollment
367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.